GlobeNewswire Inc.··NaJade Biosciences Names Chief Medical Officer, Awards $12.7M Stock Option Grant
Clinical-stage biotech Jade Biosciences appoints Dr. Edward Conner as CMO, grants 500,000 stock options valued at $12.7M as inducement under Nasdaq rules.
JBIOautoimmune diseasesclinical-stage biotechnology